Glucagon-like peptide 1-based therapies and risk of pancreatitis: a self-controlled case series analysis
Version of Record online: 3 DEC 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 23, Issue 3, pages 234–239, March 2014
How to Cite
Li, X., Zhang, Z. and Duke, J. (2014), Glucagon-like peptide 1-based therapies and risk of pancreatitis: a self-controlled case series analysis. Pharmacoepidem. Drug Safe., 23: 234–239. doi: 10.1002/pds.3542
- Issue online: 4 MAR 2014
- Version of Record online: 3 DEC 2013
- Manuscript Accepted: 6 OCT 2013
- Manuscript Revised: 1 OCT 2013
- Manuscript Received: 16 AUG 2013
|pds3542-sup-0001-documentS1.docx||Word 2007 document||72K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.